Compatibility /100
68/100
High potentialWhy talk
- TIBOK targets United States, where ZymoChem is already active — a soft-landing ZymoChem can offer.
- TIBOK likely needs funding for the next round — ZymoChem can offer investor introductions (inferred from public profile).
- Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
12.5 / 25 pts
ZymoChem can help TIBOK.
- TIBOK likely needs funding for the next round — ZymoChem can offer investor introductions (inferred from public profile).
Market bridge
36.0 / 45 pts
Direct bridge into a target market.
- TIBOK targets United States, where ZymoChem is already active — a soft-landing ZymoChem can offer.
- TIBOK is based in Mauritius (Africa): a landing pad on another continent, both ways.
Customer potential
5.5 / 10 pts
Some customer potential.
- TIBOK already has first customers in a related sector (HealthTech): Live in Mauritius — try Eva on WhatsApp at +230 5942 4894.
Sector synergy
8.5 / 10 pts
Complementary sectors.
- Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
Stage complementarity
5.5 / 10 pts
Useful peer or mentor link.
- ZymoChem is one step ahead of TIBOK (Seed): ZymoChem can share its playbook.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Market entry”: Needs ↔ offers 25, Market bridge 45, Customer potential 10, Sector synergy 10, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 65/100 — high from 50, medium from 36.

